The Globe and Mail reports in its Friday, Dec. 8, edition that with the close of IsoEnergy's merger with Consolidated Uranium, Eight Capital analyst Puneet Singh raised his target by 40 cents to $7.50. The Globe's David Leeder writes in the Eye On Equities column that Mr. Singh is sticking with his "buy" recommendation for IsoEnergy. Analysts on average target the shares at $6.15. Mr. Singh says in a note, "We see the newly merged entity as a potential near-term producer out of the U.S., with its Canadian asset base led by Larocque East/Hurricane still anchoring the portfolio, and other assets, including Coles Hill, representing option value." The Globe reported on June 22, 2022, that Mr. Singh rated IsoEnergy "buy" in new coverage. In the item, Mr. Singh said IsoEnergy's Hurricane deposit was "the best uranium discovery in the Athabasca basin since NexGen's Arrow." He added, "It is likely that IsoEnergy may have a much larger resource than our initial estimate of Larocque East." IsoEnergy shares could then be had for $3.03.